Both aggressive and hard to treat, liver cancer kills more than 650,000 a year worldwide. The American Cancer Society pegs the overall survival rate at less than 10%. Enter Aura Biosciences, a student startup that has developed an ingenious new means of delivering cancer-killing drugs to liver (and other) tumors.
For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year
Stocks slipped Monday as falling oil prices and a rash of corporate deals failed to rally investors concerned about reports on housing and testimony from Federal Reserve Chairman Ben Bernanke due later this week.
Stocks tumbled Monday afternoon, as a rash of corporate deals and a big selloff in oil prices failed to inspire investors ahead of key reports on housing and retail and testimony from Fed chief Ben Bernanke - all due later this week.